|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.505 RUB | +10.15% |
|
-.--% | - |
| Market Cap | 1.36B 105B 1.19B 1.11B 1.02B 1.91B 131B 1.94B 13.15B 5.14B 64.2B 5.09B 4.98B 222B | P/E 2021 |
-2.42x | P/E 2022 | -6.53x |
|---|---|---|---|---|---|
| Enterprise Value | 2.09B 162B 1.84B 1.71B 1.57B 2.95B 201B 2.99B 20.29B 7.93B 99.06B 7.85B 7.69B 342B | EV / Sales 2021 |
5.43x | EV / Sales 2022 | 5.51x |
| Free-Float |
95.22% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | +10.15% |
| 5 years | 2.64 |  | 7 |
| 10 years | 2.64 | | 18.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 48 | 31/12/2013 | |
Alexey Shafranov
DFI | Director of Finance/CFO | 47 | - |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Dmitriy Genkin
CHM | Chairman | 57 | 31/12/2004 |
Indrek Kasela
BRD | Director/Board Member | 54 | 31/12/2006 |
Steve Gorelik
BRD | Director/Board Member | 47 | 31/12/2006 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +10.15% | -.--% | -.--% | -.--% | 25.27M | |
| +1.13% | +1.90% | +49.17% | +161.57% | 1,057B | |
| +1.18% | +3.94% | +55.11% | +53.74% | 624B | |
| +0.62% | +1.77% | +35.73% | +80.89% | 454B | |
| +1.60% | +6.25% | +33.95% | +29.84% | 341B | |
| -0.60% | +1.52% | +35.68% | +39.76% | 297B | |
| -0.14% | +0.60% | +16.17% | +17.53% | 262B | |
| +0.09% | -2.82% | -28.29% | -41.71% | 215B | |
| +1.35% | +2.93% | +22.20% | +60.16% | 201B | |
| -0.73% | -3.13% | +14.91% | +67.50% | 162B | |
| Average | +1.53% | +1.71% | +23.46% | +46.93% | 361.4B | |
| Weighted average by Cap. | +0.80% | +1.57% | +35.92% | +77.96% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 438M 34.04B 385M 358M 329M 617M 42.21B 627M 4.25B 1.66B 20.75B 1.65B 1.61B 71.75B | 380M 29.48B 333M 310M 285M 535M 36.56B 543M 3.68B 1.44B 17.98B 1.43B 1.39B 62.15B |
| Net income | -698M -54.17B -613M -570M -523M -982M -67.17B -997M -6.77B -2.64B -33.03B -2.62B -2.56B -114B | -207M -16.11B -182M -169M -156M -292M -19.98B -297M -2.01B -786M -9.82B -779M -762M -33.97B |
| Net Debt | 693M 53.81B 609M 566M 519M 976M 66.73B 991M 6.72B 2.63B 32.81B 2.6B 2.55B 113B | 736M 57.17B 647M 601M 552M 1.04B 70.9B 1.05B 7.14B 2.79B 34.86B 2.76B 2.7B 121B |
Employees
60
Sector
Pharmaceuticals
- Stock Market
- Stocks
- LIFE Stock
Select your edition
All financial news and data tailored to specific country editions
